Skip to main content

Table 2 Rate of live, dead, and apoptotic cells in different experimental conditions

From: Priming with inflammatory cytokines is not a prerequisite to increase immune-suppressive effects and responsiveness of equine amniotic mesenchymal stromal cells

Condition

Live

Apoptotic

Dead

CTR

88.00 ± 2.12a

9.83 ± 1.23a

2.17 ± 1.02a

CM-AMSC

88.84 ± 1.28a

8.47 ± 1.94a

2.69 ± 0.82a

CM-AMSC-TNF-α

77.83 ± 0.77b

16.22 ± 0.74b

5.95 ± 0.03b

CM-AMSC-IFN-γ

77.09 ± 0.37b

15.84 ± 0.24b

7.07 ± 0.12b

CM-AMSC-TNF-α+IFN-γ

59.38 ± 0.59c

24.94 ± 1.86c

15.68 ± 1.27c

LPS

21.66 ± 6.88d

39.66 ± 9.81d

38.68 ± 6.69d

LPS+CM-AMSC

65.59 ± 2.55e

23.97 ± 2.59e

10.44 ± 2.20e

LPS+CM-AMSC-TNF-α

64.31 ± 1.48e

24.96 ± 2.73e

10.73 ± 1.30e

LPS+CM-AMSC-IFN-γ

64.87 ± 5.24e

24.00 ± 4.01e

11.13 ± 2.15e

LPS+ CM-AMSC-TNF-α+IFN-γ

64.12 ± 0.95e

22.46 ± 3.46e

13.42 ± 3.64e

  1. Different small letters superscript (a, b) in the different columns indicate statistically different comparisons (P < 0.05)